By Christie Smythe ( June 15, 2010, 6:23 PM EDT) -- A health sciences researcher admitted in court that a U.S. Food and Drug Administration report critical of Merck & Co. osteoperosis drug Fosamax had not received an official sign-off by the agency, calling into question evidence used by plaintiff Shirley Boles in a bellwether case over alleged health risks associated with the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.